These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 24585089

  • 1. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
    Gao H, Meng J, Xing H, Nie S, Xu M, Zhang S, Jin Y, Sun T, Huang H, Zhang H, Wang D, Liu L.
    Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
    [Abstract] [Full Text] [Related]

  • 2. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D, Hulchiy M, Calaby A, Nybacka Å, Byström B, Hirschberg AL.
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [Abstract] [Full Text] [Related]

  • 3. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ, Chae SJ, Choi YM, Hwang KR, Song SH, Yoon SH, Kim SM, Ku SY, Kim SH, Kim JG, Moon SY.
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [Abstract] [Full Text] [Related]

  • 4. Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study.
    Yang Q, Zhao Y, Qiu X, Zhang C, Li R, Qiao J.
    Hum Reprod; 2015 Aug; 30(8):1964-73. PubMed ID: 26040477
    [Abstract] [Full Text] [Related]

  • 5. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
    Sam S, Scoccia B, Yalamanchi S, Mazzone T.
    Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
    Mumm H, Altinok ML, Henriksen JE, Ravn P, Glintborg D, Andersen M.
    Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
    [Abstract] [Full Text] [Related]

  • 7. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J, Fan P, Liu H, Bai H, Wang Y, Zhang F.
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [Abstract] [Full Text] [Related]

  • 9. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [Abstract] [Full Text] [Related]

  • 10. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ.
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [Abstract] [Full Text] [Related]

  • 11. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA, Goss AM, Azziz R, Raju DA, Gower BA.
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [Abstract] [Full Text] [Related]

  • 12. Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure.
    Wu Y, Zhong G, Chen S, Zheng C, Liao D, Xie M.
    Hum Reprod; 2017 Apr 01; 32(4):937-943. PubMed ID: 28333243
    [Abstract] [Full Text] [Related]

  • 13. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ.
    Ann Endocrinol (Paris); 2015 Oct 01; 76(5):620-7. PubMed ID: 26514948
    [Abstract] [Full Text] [Related]

  • 14. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.
    Chen MJ, Han DS, Yang JH, Yang YS, Ho HN, Yang WS.
    Hum Reprod; 2012 Aug 01; 27(8):2476-83. PubMed ID: 22693174
    [Abstract] [Full Text] [Related]

  • 15. Expression levels of haem oxygenase-1 in the omental adipose tissue and peripheral blood mononuclear cells of women with polycystic ovary syndrome.
    Seow KM, Lin YH, Hwang JL, Wang PH, Ho LT, Lin YH, Juan CC.
    Hum Reprod; 2011 Feb 01; 26(2):431-7. PubMed ID: 21148661
    [Abstract] [Full Text] [Related]

  • 16. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D, Altinok M, Mumm H, Buch K, Ravn P, Andersen M.
    Hum Reprod; 2014 Aug 01; 29(8):1773-9. PubMed ID: 24903198
    [Abstract] [Full Text] [Related]

  • 17. Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study.
    Wang Y, Zhou W, Wu C, Zhang Y, Lin T, Sun Y, Liu W, Tao T.
    Reprod Biol Endocrinol; 2018 Mar 27; 16(1):31. PubMed ID: 29587769
    [Abstract] [Full Text] [Related]

  • 18. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.
    Hum Reprod; 2015 Oct 27; 30(10):2376-86. PubMed ID: 26269538
    [Abstract] [Full Text] [Related]

  • 19. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
    Cui L, Li G, Zhong W, Bian Y, Su S, Sheng Y, Shi Y, Wei D, Zhang W, Zhao H, Chen ZJ.
    Hum Reprod; 2015 Mar 27; 30(3):732-6. PubMed ID: 25586784
    [Abstract] [Full Text] [Related]

  • 20. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC, Guarnotta V, Forti D, Donatelli M, Dolcimascolo S, Giordano C.
    Hum Reprod; 2013 Jul 27; 28(7):1919-28. PubMed ID: 23592224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.